SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma

Conclusions:
Combined, our findings highlight a tumor-promoting role for SLC39A6 in ESCC, suggesting that SLC39A6 could serve as an early detector of high-risk subjects and prognostic biomarker. The targeting of SLC39A6 might be a potential therapeutic strategy for blocking ESCC.

Source: Journal of Translational Medicine - October 6, 2015 Category: Research Authors: Xiao-Bin CuiYao-yuan ShenTing-ting JinSu LiTing-ting LiShu-mao ZhangHao PengChun-xia LiuShu-gang LiLan YangNa LiJian-ming HuJin-Fang JiangMan LiWei-hua LiangYong LiYu-tao WeiZhen-zhu SunChuan-yue WuYun-Zhao ChenFeng Li Source Type: research